My watch list
my.bionity.com  
Login  
NEWS
Current news

Seniors and sleeping pills

The US Patient Protection and Affordable Health Care Act encourages patients to act as their own advocates for reducing unnecessary prescriptions that increase the risk of harm. The American Board of Internal Medicine Choosing Wisely® campaign echoes this message by asking older adults to r ... more

Nano shake-up

Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers, or capsules ... more

Penicillin redux

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “s ... more

Update on infringement procedure against Roche Registration Ltd.

The European Medicines Agency has concluded its inquiry into alleged non-compliance with pharmacovigilance obligations of Roche Registration Ltd and sent its report on the inquiry to the European Commission for the next steps. The inquiry is part of the infringement procedure against Roche ... more

The answer to clinical data boom

The introduction of mandates involving meaningful use of data and various governmental eHealth initiatives across the globe are fuelling the adoption of electronic medical records (EMR) and healthcare information systems (HIS) to enable universal access to patient information. The resulting ... more

Convincing performance by CHEMIE.DE at analytica 2014

A complete success - this sums up CHEMIE.DE Information Service's appearance at analytica 2014 in Munich. Europe's largest online information platform for the chemical, life science and analytics industries caught the attention of the visitors with an eye-catching, ideally placed booth and ... more

New technique to sharpen microscope images

The complexity of biology can befuddle even the most sophisticated light microscopes. Biological samples bend light in unpredictable ways, returning difficult-to-interpret information to the microscope and distorting the resulting image. New imaging technology developed at the Howard Hughes ... more

Recommendation against combined use of medicines affecting the renin-angiotensin system

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the risks of combining different classes of medicines that act on the renin-angiotensin (RAS) system, a hormone system that controls blood pressure and the volume of fluids in the body. These med ... more

Brain cell discovery could open doors to targeted cancer therapies

Fresh insights into the processes that control brain cell production could pave the way for treatments for brain cancer and other brain-related disorders. Scientists have gained new understanding of the role played by a key molecule that controls how and when nerve and brain cells are forme ... more

Decades-old mystery of how cells keep from bursting

A team led by scientists at The Scripps Research Institute (TSRI) has identified a long-sought protein that facilitates one of the most basic functions of cells: regulating their volume to keep from swelling excessively. The identification of the protein, dubbed SWELL1, solves a decades-lon ... more

All news

analytica closes with outstanding results in all areas

Despite a pilot strike, visitors from around the world flocked to the trade-fair center in Munich during the past four days. The reason: the 24th analytica. The trade fair for laboratory technology, analysis and biotechnology attracted more than 34,400 visitors to Munich (compared to 30,481 ... more

Tracing how the embryo takes over

Embryonic development is initially controlled by maternal genetic information stored in the egg. LMU researchers now describe a methodology that allows the succeeding activation of the zygotic genome to be mapped at high resolution. In multicellular organisms, the earliest steps in embryoni ... more

analytica 2014 to focus on food and plastics analysis, genetic analysis and bioanalysis

A first-rate and exciting program of events awaits visitors at the 24th analytica in Munich. From April 1 – 4, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology will once again be a center for key players in science and industry. More than 1,100 exhibitors w ... more

MolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise

MolecularHealth announced a unique agreement with GATC Biotech. GATC Biotech will provide protocols, support and extensive training of MolecularHealth’s laboratory staff. Additionally, MolecularHealth will use GATC Biotech’s LIMS (Laboratory Information Management System) in itsnewly opened ... more

Neandertal genome project reaches its goal

An international research team led by Kay Prüfer and Svante Pääbo of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, has determined a high-quality genome sequence of a Neandertal woman. The genome allows detailed insights into the relationships and population his ... more

A protein complex for the long haul

A multiprotein complex called TREX plays a key role in expression of the genetic information. Moreover, as a new study demonstrates – the longer the gene, the greater the need for TREX function. In higher organisms, the genetic information, written in the nucleotide sequences of the heredit ... more

Infected butterflies lead geneticists up the garden path

For animal species that cannot be distinguished using their external characteristics, genetic techniques such as DNA barcoding can help to identify cryptic species. An international team of researchers led by the Helmholtz Center for Environmental Research (UFZ) has brought out an article i ... more

Diaxonhit Enters into Exclusive Partnership Agreement with Japanese Tosoh Group for Marketing Immunoassay Instruments

Diaxonhit strengthens its offering in the field of immunoassays for clinical laboratories with the signing by InGen, its commercialization affiliate, of a partnership agreement with the Japanese group Tosoh Europe NV for the marketing of immunoassay instruments in France and its overseas te ... more

Frost & Sullivan: Diagnostic and Therapeutic Potential of microRNAs Stimulate Need for More Research Tools

Rapid growth in microRNA (miRNA) research over the past two years, owing to its diagnostic and therapeutic potential, has fuelled development in the global miRNA tools and services market. Of the various miRNA technologies, which include quantitative real-time polymerase chain reaction (qRT ... more

Scientists decode mystery sequences involved in gene regulation

Every cell in an organism's body has the same copy of DNA, yet different cells do different things; for example, some function as brain cells, while others form muscle tissue. How can the same DNA make different things happen? A major step forward is being announced today that has implicati ... more

All news on bioanalytics

Nano shake-up

Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers, or capsules ... more

Convincing performance by CHEMIE.DE at analytica 2014

A complete success - this sums up CHEMIE.DE Information Service's appearance at analytica 2014 in Munich. Europe's largest online information platform for the chemical, life science and analytics industries caught the attention of the visitors with an eye-catching, ideally placed booth and ... more

New technique to sharpen microscope images

The complexity of biology can befuddle even the most sophisticated light microscopes. Biological samples bend light in unpredictable ways, returning difficult-to-interpret information to the microscope and distorting the resulting image. New imaging technology developed at the Howard Hughes ... more

Analytik Jena planning merger by absorption of CyBio AG

Analytik Jena AG is planning to merge the business of its subsidiary CyBio AG, also headquartered in Jena, with its core business in the Life Science business unit. Against this backdrop, CyBio AG will be merged into Analytik Jena AG during the current financial year. A corresponding merger ... more

No compromises: Short, flexible, reusable AFM probe

JILA researchers have engineered a short, flexible, reusable probe for the atomic force microscope (AFM) that enables state-of-the-art precision and stability in picoscale force measurements. Shorter, softer and more agile than standard and recently enhanced AFM probes, the JILA tips will b ... more

Sustainable production of pharmaceutical compounds

European scientists have made ground-breaking discoveries for improving the efficiency of the production of pharmaceuticals through plant biotechnology. Biotechnological production offers a cost-effective and environmentally friendly alternative to the chemical synthesis of rare and complex ... more

Scientists disagree on responsible research

Responsible research has been put firmly on the political agenda with, for instance, EU's Horizon 2020 programme in which all research projects must show how they contribute responsibly to society. New research from the University of Copenhagen reveals that the scientists themselves place g ... more

analytica closes with outstanding results in all areas

Despite a pilot strike, visitors from around the world flocked to the trade-fair center in Munich during the past four days. The reason: the 24th analytica. The trade fair for laboratory technology, analysis and biotechnology attracted more than 34,400 visitors to Munich (compared to 30,481 ... more

Amino acid fingerprints revealed in new study

Some three billion base pairs make up the human genome—the floor plan of life. In 2003, the Human Genome Project announced the successful decryption of this code, a tour de force that continues to supply a stream of insights relevant to human health and disease. Nevertheless, the primary ac ... more

Simple microfluidic devices now have valves

Researchers at the National Institute of Standards and Technology (NIST) have added yet another innovation—miniature valves—to their ever-growing collection of inexpensive, easy-to-manufacture and highly efficient microfluidic devices made from plastic films and double-sided tape. Tradition ... more

All news on biotechnology

Toward a faster way to diagnose stroke

When someone suffers from a stroke, a silent countdown begins. A fast diagnosis and treatment can mean the difference between life and death. So scientists are working on a new blood test that one day could rapidly confirm whether someone is having a stroke and what kind. Their report appea ... more

Catching the early spread of breast cancer

When cancer spreads from one part of the body to another, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses "nano-flares" has the potential to catch these lurking, mobilized tumor cells early on. "We've taken perhaps ... more

Live cell imaging revolutionises disease diagnostics and drug discovery

Tremendous advances in electronics, optics, fluorescent tools, and molecular biology have made live cell imaging technologies more accessible to life scientists looking to understand biological dynamics and visualize cellular events in organisms. The foray of omics technologies and nanotech ... more

Information technology awakens the sleep disorder diagnostic industry

A large pool of undiagnosed patients and the growing population of the elderly in both Europe and North America point to a massive end-user market for sleep disorder diagnostics devices. The market is steadily drawing investors due to the visible tilt in preference from drugs to home care s ... more

Epigenomics and VSA receive approval to market Epi proColon

Epigenomics AG and VSA ALTA COMPLEJIDAD S.A. announced that VSA has received approval to market the Epigenomics Epi proColon® kit for the blood-based detection of colorectal cancer (CRC) in Argentina. “The Epigenomics assay enables VSA to extend its market leading efforts to improve access ... more

Boom in smart pills will reach a new peak by 2018-2020

The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. While certain smart pill applications, such as imaging and sensing, have been successfully commercialized, others like drug delivery and surgery are yet to be proven clinically ... more

Novel mTOR blood tests for dementia

Cytox Ltd announced the start of two landmark exploratory clinical trials designed to evaluate a new blood assay platform that could potentially assist in the evaluation of an individual’s risk for dementia and Alzheimer’s. The two studies will obtain samples from patients in Europe and in ... more

Diagnosis just a breath away with new laser

University of Adelaide physics researchers have developed a new type of laser that will enable exciting new advances in areas as diverse as breath analysis for disease diagnosis and remote sensing of critical greenhouse gases. Published in the journal Optics Letters, the researchers from th ... more

Cell membrane model studied as future diagnostic tool

Researchers at the National Institute of Standards and Technology (NIST) and in Lithuania have used a NIST-developed laboratory model of a simplified cell membrane to accurately detect and measure a protein associated with a serious gynecological disease, bacterial vaginosis (BV), at extrao ... more

analytica 2014 to focus on food and plastics analysis, genetic analysis and bioanalysis

A first-rate and exciting program of events awaits visitors at the 24th analytica in Munich. From April 1 – 4, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology will once again be a center for key players in science and industry. More than 1,100 exhibitors w ... more

All news on diagnostics

Eppendorf: Sales stable in 2013

In fiscal year 2013, the Eppendorf Group achieved sales of €502.7 million (prior year: €520.2 million). When adjusted for currency effects, sales were only slightly lower than in the previous year (-0.4%). Income from operations (EBIT) decreased to €93.8 million (prior year: €101.5 million) ... more

analytica closes with outstanding results in all areas

Despite a pilot strike, visitors from around the world flocked to the trade-fair center in Munich during the past four days. The reason: the 24th analytica. The trade fair for laboratory technology, analysis and biotechnology attracted more than 34,400 visitors to Munich (compared to 30,481 ... more

Good vibrations: Using light-heated water to deliver drugs

Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targ ... more

Sartorius Reviews Fiscal 2013 Results

The Sartorius Group closed fiscal 2013 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Group CEO Dr. Joachim Kreuzburg emphasized that the company not only achieved all financial targets, but also has successfully moved forward with its Sa ... more

The thousand-droplets test

In the future, an entire chemistry lab could be accommodated in a tiny little droplet. While simple reactions already work in these simplest models of an artificial cell now a group of scientists of the Cluster of Excellence Nanosystems Initiative Munich (NIM) have established and investiga ... more

Altmann Analytik acquires lab supplier Dinkelberg analytics

Munich-based Altmann Analytik GmbH & Co. KG announced that it has acquired Dinkelberg analytics GmbH from Gablingen with effect from January 2014. Dinkelberg analytics was founded in 1922 and has produced for more than 50 years their own lab instruments, such as water baths or vacuum packag ... more

analytica 2014: New special exhibit for occupational health and safety

Many laboratory workers believe they know the dangers of their work inside out. However, the fact that work accidents still occur on a regular basis shows just how important it is to keep abreast of safety issues. For the first time ever, the analytica 2014 is offering the Special Exhibit f ... more

Sartorius appoints internationally experienced laboratory manager

Effective April 1, 2014, Michael Melingo will head marketing, sales and services of the Lab Products & Services Division at Sartorius. He will therefore succeed Dominique Baly, who will retire from the company as planned after reaching retirement age. Michael Melingo will report to CEO and ... more

Successful year for Sartorius

According to preliminary figures for 2013, the Sartorius Group grew dynamically again in 2013 and further increased its profitability. The company fully achieved its financial targets. For the current fiscal year, Sartorius expects positive business development as well. "Fiscal 2013 was a s ... more

analytica 2014 to focus on food and plastics analysis, genetic analysis and bioanalysis

A first-rate and exciting program of events awaits visitors at the 24th analytica in Munich. From April 1 – 4, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology will once again be a center for key players in science and industry. More than 1,100 exhibitors w ... more

All news on lab technology

Nano shake-up

Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers, or capsules ... more

Penicillin redux

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “s ... more

Update on infringement procedure against Roche Registration Ltd.

The European Medicines Agency has concluded its inquiry into alleged non-compliance with pharmacovigilance obligations of Roche Registration Ltd and sent its report on the inquiry to the European Commission for the next steps. The inquiry is part of the infringement procedure against Roche ... more

Recommendation against combined use of medicines affecting the renin-angiotensin system

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the risks of combining different classes of medicines that act on the renin-angiotensin (RAS) system, a hormone system that controls blood pressure and the volume of fluids in the body. These med ... more

Enzyme 'wrench' could be key to more effective antibiotics

Builders and factory workers know that getting a job done right requires precision and specialized tools. The same is true when you're building antibiotic compounds at the molecular level. New findings from North Carolina State University may turn an enzyme that acts as a specialized "wrenc ... more

Yeast provides genetic clues on drug response

Why do people respond differently to the same drug? For the first time, researchers have untangled genetic and environmental factors related to drug reactions, bringing us a step closer to predicting how a drug will affect us. Researchers at the University of British Columbia exposed 6,000 ... more

Sustainable production of pharmaceutical compounds

European scientists have made ground-breaking discoveries for improving the efficiency of the production of pharmaceuticals through plant biotechnology. Biotechnological production offers a cost-effective and environmentally friendly alternative to the chemical synthesis of rare and complex ... more

Kill resistant tumor cells

Researchers from the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter, have found that an agent that inhibits mitochondrial division can overcome tumor cell resistance to a commonly used cancer drug, and that the combination of the two induces rapid and syn ... more

Merck Serono announces license agreement with Auxogyn

Merck Serono announced an exclusive license agreement with Auxogyn, Inc., Menlo Park, California, USA, a company dedicated to advancing women’s reproductive health, for Auxogyn’s proprietary Early Embryo Viability Assessment (Eeva®) Test. more

Pharmocogenomics has not fulfilled its promise

From 1997 to 2010, despite promises made by the international scientific community, pharmacogenomic research produced few studies focusing on rare, orphan and tropical diseases prevalent in developing countries. Catherine Olivier, bioethics research at the University of Montreal's School of ... more

All news on pharma

Seniors and sleeping pills

The US Patient Protection and Affordable Health Care Act encourages patients to act as their own advocates for reducing unnecessary prescriptions that increase the risk of harm. The American Board of Internal Medicine Choosing Wisely® campaign echoes this message by asking older adults to r ... more

Nano shake-up

Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers, or capsules ... more

Penicillin redux

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “s ... more

Update on infringement procedure against Roche Registration Ltd.

The European Medicines Agency has concluded its inquiry into alleged non-compliance with pharmacovigilance obligations of Roche Registration Ltd and sent its report on the inquiry to the European Commission for the next steps. The inquiry is part of the infringement procedure against Roche ... more

The answer to clinical data boom

The introduction of mandates involving meaningful use of data and various governmental eHealth initiatives across the globe are fuelling the adoption of electronic medical records (EMR) and healthcare information systems (HIS) to enable universal access to patient information. The resulting ... more

Recommendation against combined use of medicines affecting the renin-angiotensin system

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the risks of combining different classes of medicines that act on the renin-angiotensin (RAS) system, a hormone system that controls blood pressure and the volume of fluids in the body. These med ... more

Brain cell discovery could open doors to targeted cancer therapies

Fresh insights into the processes that control brain cell production could pave the way for treatments for brain cancer and other brain-related disorders. Scientists have gained new understanding of the role played by a key molecule that controls how and when nerve and brain cells are forme ... more

Decades-old mystery of how cells keep from bursting

A team led by scientists at The Scripps Research Institute (TSRI) has identified a long-sought protein that facilitates one of the most basic functions of cells: regulating their volume to keep from swelling excessively. The identification of the protein, dubbed SWELL1, solves a decades-lon ... more

How mechanical forces affect T-cell recognition and signaling

T-cells are the body's sentinels, patrolling every corner of the body in search of foreign threats such as bacteria and viruses. Receptor molecules on the T-cells identify invaders by recognizing their specific antigens, helping the T-cells discriminate attackers from the body's own cells. ... more

Fruit flies have latent bioluminescence

New research from scientists at the University of Massachusetts Medical School shows that fruit flies are secretly harboring the biochemistry needed to glow in the dark —otherwise known as bioluminescence. The key to activating this latent ability is a novel synthetic analog of D-luciferin ... more

All news on healthcare
News by department
  • Products

    BioGaia enters new agreement with Nestlé

    In February 2012 BioGaia sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle for the remainder of the patent lifetime. BioGaia received EUR 40 million up-front and a commitment to a further EUR 10.8 million during the period 2014 to 2017 upon achieveme ... more

    All the important trade fairs, congresses, seminars and webinars at a glance

    Trade fairs, congresses, conferences, seminars and webinars – companies and organisations in chemistry, life sciences and analytics host a wide spectrum of events. But where do you find training opportunities for your profession? Which conferences can keep you up-to-date with developments i ... more

    Novel mTOR blood tests for dementia

    Cytox Ltd announced the start of two landmark exploratory clinical trials designed to evaluate a new blood assay platform that could potentially assist in the evaluation of an individual’s risk for dementia and Alzheimer’s. The two studies will obtain samples from patients in Europe and in ... more

  • Business

    Convincing performance by CHEMIE.DE at analytica 2014

    A complete success - this sums up CHEMIE.DE Information Service's appearance at analytica 2014 in Munich. Europe's largest online information platform for the chemical, life science and analytics industries caught the attention of the visitors with an eye-catching, ideally placed booth and ... more

    Analytik Jena planning merger by absorption of CyBio AG

    Analytik Jena AG is planning to merge the business of its subsidiary CyBio AG, also headquartered in Jena, with its core business in the Life Science business unit. Against this backdrop, CyBio AG will be merged into Analytik Jena AG during the current financial year. A corresponding merger ... more

    Merck Millipore and VWR Extend Western European Distribution Agreement

    Merck Millipore, the Life Science division of Merck, announced a new non-exclusive, preferred distribution agreement for Western Europe with VWR a global provider of laboratory supplies, equipment and services. The contract includes a range of Merck Millipore products and reagents for chemi ... more

  • Price Development

    BASF increases prices for Vitamin E and A feed grade

    BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

    Significant overall survival benefit observed with radium 223 in patients with castration-resistant prostate cancer

    Algeta ASA announced that data from the pivotal phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial of its drug radium Ra 223 dichloride (radium 223) in castration-resistant prostate cancer (CRPC) patients with symptomatic bone metastases and no known visceral metastatic di ... more

    BASF increases prices for vitamin B2

    BASF globally increases the price for vitamin B2-products for human and animal nutrition by 10% with immediate effect respectively according to existing contracts terms at the earliest possible date. more

  • Research

    Seniors and sleeping pills

    The US Patient Protection and Affordable Health Care Act encourages patients to act as their own advocates for reducing unnecessary prescriptions that increase the risk of harm. The American Board of Internal Medicine Choosing Wisely® campaign echoes this message by asking older adults to r ... more

    Nano shake-up

    Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers, or capsules ... more

    Penicillin redux

    Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “s ... more

  • People

    Merck Supervisory Board nominates candidates for new elections in May

    The Supervisory Board of Merck nominated the candidates for the six shareholder representatives to be elected by the Annual General Meeting. In addition,the Supervisory Board also resolved to propose to the Annual General Meeting a 20 euro cent dividend increase to € 1.90 per share, asrecom ... more

    Personnel changes at Alchemia

    Alchemia Limited announced the appointment of Thomas Liquard as Chief Executive Officer following the departure of Charles Walker. Mr Liquard, who joined Alchemia in December 2013 as Chief Operating Officer, brings significant commercial and managerial expertise to the company having most r ... more

    Merck Appoints Simon Sturge as New Head of Biosimilars Unit

    Merck announced that Simon Sturge (54) will join the company from Boehringer Ingelheim effective March 1, 2014, to head the biosimilars unit. In his new role Sturge will report to Stefan Oschmann, Member of Merck’s Executive Board and responsible for the company’s pharmaceutical businesses. ... more

  • Finances

    Eppendorf: Sales stable in 2013

    In fiscal year 2013, the Eppendorf Group achieved sales of €502.7 million (prior year: €520.2 million). When adjusted for currency effects, sales were only slightly lower than in the previous year (-0.4%). Income from operations (EBIT) decreased to €93.8 million (prior year: €101.5 million) ... more

    Merck extends offer for AZ Electronic Materials

    Merck announced that it agreed to further extend the timetable of its recommended cash offer for AZ Electronic Materials (AZ). Accordingly, the offer to AZ shareholders has been extended until 1.00 p.m. (GMT) on April 18, 2014. more

    BioGaia enters new agreement with Nestlé

    In February 2012 BioGaia sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle for the remainder of the patent lifetime. BioGaia received EUR 40 million up-front and a commitment to a further EUR 10.8 million during the period 2014 to 2017 upon achieveme ... more

  • Cooperation

    Merck Serono announces license agreement with Auxogyn

    Merck Serono announced an exclusive license agreement with Auxogyn, Inc., Menlo Park, California, USA, a company dedicated to advancing women’s reproductive health, for Auxogyn’s proprietary Early Embryo Viability Assessment (Eeva®) Test. more

    Merck Serono Enters into Research Agreement with Pfizer and Broad Institute

    Merck Serono announced that its U.S. affiliate EMD Serono has signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S. The collaboration is focused on the genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) patients. ... more

    Biotechnological extraction of rare earth metals

    BRAIN AG and Seltenerden Storkwitz AG announce the expansion of a strategic partnership in the field of biotechnological mining of rare earth metals. The two partners aim to mine rare earth deposits using sustainable microbiological processes. Mining the rare earth metal scandium using this ... more

  • Technology

    Merck Serono announces license agreement with Auxogyn

    Merck Serono announced an exclusive license agreement with Auxogyn, Inc., Menlo Park, California, USA, a company dedicated to advancing women’s reproductive health, for Auxogyn’s proprietary Early Embryo Viability Assessment (Eeva®) Test. more

    All the important trade fairs, congresses, seminars and webinars at a glance

    Trade fairs, congresses, conferences, seminars and webinars – companies and organisations in chemistry, life sciences and analytics host a wide spectrum of events. But where do you find training opportunities for your profession? Which conferences can keep you up-to-date with developments i ... more

    Innovative technology for the enrichment of free-circulating DNA

    After a two year period of development Analytik Jena has launched an innovative technology to enrich and isolate free-circulating DNA. Free-circulating DNA occurs in plasma, serum, and urine, among other things, but only in small fragments and very low concentrations. In order to isolate th ... more

  • Laws

    EU rules are denying children latest cancer drugs

    Children with cancer are being denied new, potentially life-saving drugs, because EU rules are allowing companies to trial some drugs only in adults, leading cancer experts warn. Changes to how EU rules are implemented could allow children access to a goldmine of potential cancer drugs whic ... more

    European Medicines Agency reveals new structure

    The European Medicines Agency (EMA) has announced details of its new organisational structure. The changes fundamentally reorganise the Agency’s operations to support better its public and animal health mission, and its role as part of the European medicines regulatory system. The new struc ... more

    Creating a ‘Window to the Brain’

    A team of University of California, Riverside researchers have developed a novel transparent skull implant that literally provides a “window to the brain”, which they hope will eventually open new treatment options for patients with life-threatening neurological disorders, such as brain can ... more

  • Market

    The answer to clinical data boom

    The introduction of mandates involving meaningful use of data and various governmental eHealth initiatives across the globe are fuelling the adoption of electronic medical records (EMR) and healthcare information systems (HIS) to enable universal access to patient information. The resulting ... more

    Drug developers rawn to orphan drugs market

    The global orphan drugs market presents plenty of opportunities for new drug development – while there are only 172 approved orphan therapies, over 6,800 orphan diseases exist according to the United States National Institute of Health (NIH). Advancements in drug discovery capabilities coup ... more

    Next-generation therapeutics for infectious diseases conquer the global spotlight

    The available antivirals for commonly occurring infections such as respiratory syncytial virus (RSV) and influenza are characterised by variable response, poor tolerability and suboptimal dosing regimens, limiting their regular use and efficacy. Likewise, the development of resistance to al ... more

  • Politics

    Update on infringement procedure against Roche Registration Ltd.

    The European Medicines Agency has concluded its inquiry into alleged non-compliance with pharmacovigilance obligations of Roche Registration Ltd and sent its report on the inquiry to the European Commission for the next steps. The inquiry is part of the infringement procedure against Roche ... more

    Recommendation against combined use of medicines affecting the renin-angiotensin system

    The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the risks of combining different classes of medicines that act on the renin-angiotensin (RAS) system, a hormone system that controls blood pressure and the volume of fluids in the body. These med ... more

    EMA announces final steps for its clinical trial data policy

    The European Medicines Agency (EMA) will launch a final round of targeted consultations with key stakeholders on its draft policy on proactive publication of and access to clinical trial data at the beginning of May. This will give key stakeholders and the Agency the opportunity to address ... more

  • Manufacturing

    Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility

    Merck announced a € 80 million investment in a new pharmaceutical manufacturing facility, to be located in the Nantong Economical Technological Development Area (NETDA), in the Greater Shanghai region (Yangtze River Delta area). “This further investment in China reflects Merck’s long-term c ... more

    Cargill and Evolva move into pilot scale ahead of schedule for fermentation-based steviol glycosides

    Cargill and Evolva Holding SA announced that their development program for fermentation-based steviol glycosides is moving into pilot scale ahead of schedule, potentially making it available for commercialization sooner than expected.  Earlier this year, Cargill and Evolva entered into an a ... more

    BIOTECHNICA 2013: spotlight on the food industry

    The Innovation in Food Marketplace is a new addition to the BIOTECHNICA show’s food biotechnology lineup. It takes a comprehensive look at the role of biotechnology in the production of safe, high-quality and ecologically sustainable food. The iFOOD Conference is also new. There are a numbe ... more

  • Career

    All the important trade fairs, congresses, seminars and webinars at a glance

    Trade fairs, congresses, conferences, seminars and webinars – companies and organisations in chemistry, life sciences and analytics host a wide spectrum of events. But where do you find training opportunities for your profession? Which conferences can keep you up-to-date with developments i ... more

    Merck Serono Announces Innovation Cup 2014

    Merck Serono, the biopharmaceutical division of Merck, announced the start of the Merck Serono Innovation Cup 2014. This worldwide initiative is aimed at graduate students and postdocs in the fields of medicine, biotechnology, bioinformatics, biochemistry and pharmacy, who are interested in ... more

    New IT-management at Merck

    Merck announced that James Stewart (52) will become Chief Information Officer (CIO) of the Merck Group as of October 1, 2013. In his new position, Stewart will report to Kai Beckmann, member of the Merck Executive Board. Stewart succeeds Frédéric Wohlwend, who has decided to pursue new oppo ... more

News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE